Wells Fargo
EDVA

Wells Fargo’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Wells Fargo’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$101 – 7385
2024
Q1 		$101 Hold
1
– – ﹤0.01% 6659
2023
Q4 		$117 Hold
1
– – ﹤0.01% 6723
2023
Q3 		$117 Hold
1
– – ﹤0.01% 6729
2023
Q2 		$239 Hold
1
– – ﹤0.01% 6649
2023
Q1 		$328 Hold
1
– – ﹤0.01% 6641
2022
Q4 		$188 Hold
1
– – ﹤0.01% 6635
2022
Q3 		$0 Hold
1
– – ﹤0.01% 7257
2022
Q2 		$0 Hold
1
– – ﹤0.01% 7386
2022
Q1 		$0 Hold
1
– – ﹤0.01% 7703
2021
Q4 		$0 Hold
1
– – ﹤0.01% 7718
2021
Q3 		$0 Buy
+1
New +$452 ﹤0.01% 7430

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SCTC
Sanibel Captiva Trust Company Sanibel, Florida $4.02B AUM 34.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo's EDVA Position: Q2 2024 in Review

Wells Fargo sold out of Endovia Health Sciences, Inc. (EDVA) in Q2 2024, closing a stake of 1 share — an estimated $101 sold.

Wells Fargo first reported a position in EDVA in Q3 2021 and held it in 11 quarters. The position peaked at $328 in Q1 2023. 31 funds tracked by Wall St. Rank hold EDVA as of Q2 2024.

  • Wells Fargo reported no remaining Endovia Health Sciences, Inc. position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 1 Endovia Health Sciences, Inc. share in Q2 2024, an estimated $101.
  • Wells Fargo first reported a position in Endovia Health Sciences, Inc. in Q3 2021 and held it in 11 quarters.
  • Wells Fargo's Endovia Health Sciences, Inc. position peaked at $328 in Q1 2023.
  • 31 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.